Louise Baussard

Louise Baussard

Auto-generated profile, based on publicly available information

Louise Baussard

Univ. Paul Valéry Montpellier 3, EPSYLON UR 4556, F34000, Montpellier, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Scandinavian Journal of Caring Sciences
Verified
Journal Article
Closed access
PDF file
BPBertrand Porro
Bertrand Porro
AMAude Michel
Aude Michel
CZCécile Zinzindohoué
Cécile Zinzindohoué
PBPierre Bertrand
Pierre Bertrand
EMEmilie Monrigal
Emilie Monrigal
FCFlorence Cousson‐Gélie
Florence Cousson‐Gélie

11 December 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LMLucile Montalescot
Lucile Montalescot
LBLouise Baussard
Louise Baussard
Elodie CharbonnierElodie Charbonnier
Elodie Charbonnier
Background: Digital interventions offer vital support for patients with cancer through education, behavior change, and monitoring. Despite their potential, patient adherence to and engagement with these self-help interventions is challenging. Factors like user characteristics, technology, and intervention design influence adherence and engagement. Existing reviews have gaps in exploring diverse factors associated with adherence in cancer care. Objective: This systematic review aims to identify factors influencing adherence to and engagement with digital interventions with self-help components in cancer care. It examined sociodemographic, psychosocial, health-related, and intervention-related factors that affect patients’ adherence to and engagement with these digital health solutions. Methods: Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, a search was conducted across PubMed, Embase, Cochrane Library, and PsycINFO to find studies published from January 2010 to September 2021. The studies included in this review focused on adult patients with cancer using digital interventions with self-help features. Data were extracted and synthesized using a standardized approach. Factors associated with adherence were synthesized according to their type—sociodemographic factors, psychosocial factors, health-related factors, technology-related factors, and intervention-related factors. Results: Among 9386 studies initially screened, 61 (0.6%) were eligible for analysis. These studies covered diverse eHealth intervention types, cancer types, and outcome measures. Investigating the determinants of adherence to and engagement with digital interventions was the main objective for 43% (26/61) of the included studies. Adherence and engagement were gauged using varied measures, such as dropout rates, log-ins, and self-reported measures. Results regarding factors associated with adherence and engagement were inconsistent across studies. Most sociodemographic (eg, age) and health-related factors (eg, cancer stage) yielded mixed outcomes. However, comorbidity consistently predicted lower adherence and engagement. Results regarding psychosocial factors were more stable across studies. Specifically, higher social support was associated with lower adherence and engagement. Finally, intervention-related factors like intervention type or human support showed conflicting results. Adopting an intersectional perspective revealed that specificities vary according to intervention goals and the operationalization of adherence versus engagement, with women being more adherent and engaged than men in interventions targeting distress. When focusing on adherence rather than engagement, older patients were more adherent than younger patients. Conclusions: This review highlights the complexity of adherence to and engagement with digital interventions in cancer care. While some factors, notably comorbidities and low social support, were consistently linked to adherence and engagement, others displayed mixed associations. The review underscores the need for standardizing measures, investigating specific intervention features, and enhancing study quality to optimize digital interventions for patients with cancer. Further research is crucial to better understand and improve adherence to digital health solutions in cancer care. Trial Registration: PROSPERO CRD42021281028; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=281028

1 October 2018 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
LBLouise Baussard
Louise Baussard
MCMarion Carayol
Marion Carayol
BPBertrand Porro
Bertrand Porro
FBFanny Baguet
Fanny Baguet
FCFlorence Cousson-Gelie
Florence Cousson-Gelie

1 February 2017 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
LBLouise Baussard
Louise Baussard
ASAnne Stoebner-Delbarre
Anne Stoebner-Delbarre
LBLaurence Bonnabel
Laurence Bonnabel
MHMarie-Eve Huteau
Marie-Eve Huteau
AGAurélie Gastou
Aurélie Gastou
FCFlorence Cousson-Gélie
Florence Cousson-Gélie

10 October 2024 in Cancer Medicine
Verified
Journal Article
Open access
LBLouise Baussard
Louise Baussard
MEMarie Ernst
Marie Ernst
ADAnh Nguyet Diep
Anh Nguyet Diep
GJGuy Jerusalem
Guy Jerusalem
AVAudrey Vanhaudenhuyse
Audrey Vanhaudenhuyse
CGCharlotte GREGOIRE
Charlotte GREGOIRE
Background: Understanding cancer symptom cluster through network analyses is a new approach in oncology, revealing interconnected and influential relationships among reported symptoms. We aimed to assess these relationships using network analysis in posttreatment breast cancer patients, focusing on the five dimensions of cancer‐related fatigue (CRF), and on other common difficulties encountered by oncological patients (i.e., pain, anxiety, depression, sleep difficulties, cognitive impairments, and emotion regulation and mental adaptation difficulties).Method: This study involved a complementary analysis of data from two interventional studies. Participants completed questionnaires before and after the intervention, with baseline scores being used in this article. Partial correlation network analysis modeled the relationships between symptoms in five distinct networks, each of them including one specific dimension of CRF. The core symptom in each network was identified based on the highest centrality indices.Results: Depression emerged as the core symptom in all networks, strongly associated with all fatigue dimensions (partial correlations ranging from 0.183 to 0.269) except mental fatigue. These findings indicate robust connections between symptoms, as variations in depression scores directly or indirectly influence fatigue and other symptoms within the cluster.Conclusion: Our results support the multidimensional aspect of CRF, and its links with other common symptoms. To effectively reduce patient CRF, interventions should address not only fatigue but also the closely related symptoms from the cluster, such as depression, given its centrality in the cluster.Trial Registration: ClinicalTrials.gov (NCT03144154 and NCT04873661). Retrospectively registered on May 1, 2017 and April 29, 2021, respectively.